1. Wasylaschuk WR, Harmon PA, Wagner G, Harman AB, Templeton AC, Xu H, et al. Evaluation of hydroperoxides in common pharmaceutical excipients. J Pharm Sci. 2007;96:106–16.
2. Narang AS, Rao VM, Desai DS. Effect of antioxidants and silicates on peroxides in povidone. JPharmSci Elsevier. 2012;101:127–39.
3. Guideline IHT. Q3B (R2) Impurities in new drug products (2006). The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH).
4. Hovorka SW, Schöneich C. Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition. J Pharm Sci. 2001;90:253–69.
5. Tallon MA, Malawer EG, Machnicki NI, Brush PJ, Wu CS, Cullen JP. The effect of crosslinker structure upon the rate of hydroperoxide formation in dried, crosslinked poly (vinylpyrrolidone). Journal of applied polymer science. Wiley Online Library. 2008;107:2776–85.